DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
+9.26%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$398M
AUM Growth
+$398M
Cap. Flow
+$11.1M
Cap. Flow %
2.78%
Top 10 Hldgs %
51.36%
Holding
92
New
12
Increased
23
Reduced
18
Closed
5

Top Buys

1
ACET icon
Adicet Bio
ACET
$6.24M
2
SNDX icon
Syndax Pharmaceuticals
SNDX
$4.72M
3
CBAY
Cymabay Therapeutics
CBAY
$4.27M
4
AXGN icon
Axogen
AXGN
$3.11M
5
MEIP icon
MEI Pharma
MEIP
$3M

Top Sells

1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$11.8M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4.13M
3
KDMN
Kadmon Holdings, Inc.
KDMN
$2.74M
4
AFMD
Affimed
AFMD
$2.17M
5
GLPG icon
Galapagos
GLPG
$1.93M

Sector Composition

1 Healthcare 94.95%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
INFI
76
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$531K 0.13%
236,160
– –
PHVS icon
77
Pharvaris
PHVS
$1.41B
$528K 0.13%
36,720
+1,646
+5% +$23.7K
ADAP
78
Adaptimmune Therapeutics
ADAP
$13.9M
$511K 0.13%
+136,266
New +$511K
INGN icon
79
Inogen
INGN
$213M
$510K 0.13%
15,000
– –
BOLT icon
80
Bolt Biotherapeutics
BOLT
$9.29M
$490K 0.12%
100,000
– –
MDGL icon
81
Madrigal Pharmaceuticals
MDGL
$9.7B
$475K 0.12%
5,600
– –
SRGA
82
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$415K 0.1%
579,710
– –
ANNX icon
83
Annexon
ANNX
$225M
$354K 0.09%
30,796
+7,500
+32% +$86.2K
GNFT
84
Genfit
GNFT
$198M
$302K 0.08%
60,448
-128,101
-68% -$640K
LCTX icon
85
Lineage Cell Therapeutics
LCTX
$281M
$196K 0.05%
+80,000
New +$196K
KDMN
86
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-314,561
Closed -$2.74M
DRNA
87
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-587,456
Closed -$11.8M
ALPN
88
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
– –
-111,501
Closed -$1.19M
NTBL
89
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
– –
-55,000
Closed -$113K
IFRX icon
90
InflaRx
IFRX
$117M
– –
-600,000
Closed -$1.55M
1 2 3
4